Home Data Calendar Blog

RCUS

Tables

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Common Stock Value 1617.001602.001582.001561.001311.001291.001267.001226.001206.000.010.010.010.010.010.010.010.010.010.010.000.000.000.000.000.00NANANANANA
Weighted Average Number Of Diluted Shares Outstanding NA91.4091.1086.20NA74.6073.2073.00NA72.2471.8071.20NA70.11NANA63.5365.1548.5644.28NA43.94NANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic NA91.4091.1086.20NA74.6073.2073.00NA72.2471.8071.20NA70.11NANA63.5362.6050.1545.95NA45.7945.4144.53NA44.4544.4511.60NA3.99
Earnings Per Share Basic -1.03-1.00-1.02-0.05-1.08-0.94-1.04-1.09-0.93-0.90NANA4.04-1.11NANA-0.870.03NANA-0.37-0.51NANANANANANANANA
Earnings Per Share Diluted -1.03-1.00-1.02-0.05-1.08-0.94-1.04-1.09-0.93-0.90NANA3.99-1.11NANA-0.870.03NANA-0.37-0.51NANANANANANANANA

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Revenue From Contract With Customer Excluding Assessed Tax -181.0048.0039.00145.0031.0032.0029.0025.0033.6633.5826.7618.00354.509.469.469.469.4964.531.751.759.751.751.751.751.564.291.251.251.250.16
Revenues 26.0048.0039.00145.0031.0032.0029.0025.0033.6633.5826.7618.00354.509.469.469.469.4964.531.751.759.751.751.751.751.564.291.251.251.250.16
Operating Expenses 129.00153.00145.00161.00122.00112.00112.00111.00108.10102.9895.7485.1973.2387.6085.6082.2161.5062.9847.1230.1527.2825.0030.9120.5215.0516.4417.1514.5814.5923.30
Research And Development Expense 101.00123.00115.00109.0093.0082.0084.0081.0080.2076.6869.9161.2149.9471.2568.7766.3948.7151.8035.6923.1420.6917.2425.0015.5511.4412.8613.7011.6512.1521.43
General And Administrative Expense 28.0030.0030.0032.0029.0030.0028.0030.0027.9026.2925.8423.9723.3016.3416.8315.8212.7911.1811.437.016.597.765.914.973.613.583.452.932.451.86
Operating Income Loss -103.00-105.00-106.00-16.00-91.00-80.00-83.00-86.00-74.44-69.40-68.98-67.18281.27-78.14-76.14-72.75-52.011.55-45.38-28.40-17.53-23.25-29.16-18.77-13.48-12.14-15.90-13.33-13.34-23.13
Allocated Share Based Compensation Expense 17.0019.0020.0020.0018.0018.0018.0019.0016.5216.2615.6816.5414.2914.5913.3712.768.076.004.473.46NA2.742.131.67NA1.051.120.66NA0.14
Profit Loss -94.00-92.00-93.00-4.00-81.00-71.00-75.00-80.00-67.46-64.92-66.63-67.99279.37-77.97-75.97-72.59-51.851.82-45.07-27.75-16.60-22.35-28.09-17.67-12.29-10.81-13.53-12.95-13.21NA
Other Comprehensive Income Loss Net Of Tax NA2.00NA-1.00NA1.00NA3.00NA-2.56-2.58-3.40NA-0.05-0.04-0.05NA-0.06-0.140.22NA-0.060.080.14NA-0.030.01-0.06NANA
Net Income Loss -94.00-92.00-93.00-4.00-81.00-71.00-75.00-80.00-67.46-64.92-66.63-67.99279.37-77.97-75.97-72.59-51.851.82-45.07-27.75-16.60-22.35-28.09-17.67-12.29-10.81-13.53-12.95-13.21-23.12
Comprehensive Income Net Of Tax -95.00-90.00-93.00-5.00-78.00-70.00-75.00-77.00-64.92-67.48-69.22-71.39278.20-78.02-76.01-72.64-51.891.76-45.22-27.53-16.59-22.41-28.01-17.53-12.29-10.84-13.52-13.01-13.24-23.11

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Assets 1150.001252.001186.001293.001095.001191.001220.001254.001345.001393.821476.771543.431591.90839.29898.77935.12772.29811.08481.39176.14203.11216.96238.97258.53274.93286.72293.87305.40190.49NA
Liabilities And Stockholders Equity 1150.001252.001186.001293.001095.001191.001220.001254.001345.001393.821476.771543.431591.90839.29898.77935.12772.29811.08481.39176.14203.11216.96238.97258.53274.93286.72293.87305.40190.49NA
Stockholders Equity 485.00565.00635.00707.00462.00520.00566.00600.00657.00698.70747.39796.58841.45542.61604.55664.79502.30544.42428.71140.64163.84177.23196.65221.57234.94245.12254.57266.59-72.33NA

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Assets Current 1016.001127.001022.001064.00831.00882.00986.001015.001067.001101.121227.471264.231261.75545.29745.95841.87735.82797.20471.60166.22192.71200.49227.73245.01258.95265.28267.44282.07176.87NA
Cash And Cash Equivalents At Carrying Value 150.00201.00156.00185.00127.00184.00230.00238.00206.00217.65272.63548.78147.91179.43320.48390.26173.41221.85285.1967.3357.9478.9976.0768.5071.0674.89170.00198.1298.4318.31
Prepaid Expense And Other Assets Current 18.0022.0025.0034.0034.0031.0022.0028.0019.0021.6215.6718.5315.6217.5721.978.685.4711.828.668.014.304.223.273.082.322.331.551.831.14NA
Available For Sale Securities Debt Securities 992.001091.001009.001095.00866.00950.001010.001044.001138.001191.921271.111342.37681.30NANANA735.09NANANANANANANANANANANANANA

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Property Plant And Equipment Gross 88.00NANANA82.00NANANA58.00NANANA50.18NANANA25.09NANANA20.5520.3819.8419.6218.7518.4618.2316.6215.21NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 41.00NANANA31.00NANANA23.00NANANA17.73NANANA14.29NANANA11.2210.379.488.607.646.705.724.813.98NA
Property Plant And Equipment Net 47.0048.0049.0051.0051.0050.0045.0037.0035.0033.8933.4233.4832.4528.8223.8114.8510.818.738.268.769.3310.0110.3611.0311.1111.7612.5111.8111.23NA
Other Assets Noncurrent 73.0075.0075.0078.00106.00108.00109.00112.00114.0010.6010.5210.897.737.905.786.186.252.251.320.960.870.260.320.320.280.200.200.201.50NA
Available For Sale Debt Securities Amortized Cost Basis 992.001090.001010.001096.00866.00953.001014.001048.001145.001201.721278.351347.03682.56NANANA735.04NANANANANANANANANANANANANA

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Liabilities Current 226.00215.00199.00204.00184.00200.00180.00179.00193.00177.18164.02161.25166.08142.87130.37132.06121.67162.8740.0221.0022.7121.0626.5119.0016.9316.6116.3814.2612.73NA
Accounts Payable Current 18.0013.0015.0016.0017.0017.0012.0028.0020.0010.5521.9818.0910.2613.2216.9624.5415.688.1012.052.434.702.902.452.833.102.115.393.923.82NA
Taxes Payable Current 1.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Liabilities Current 123.0097.0071.0064.0076.0080.0065.0054.0076.002.982.47NA0.050.210.382.383.573.421.461.411.481.491.511.541.561.581.651.730.77NA
Contract With Customer Liability Current 85.00105.00113.00124.0091.00103.00103.0097.0097.00103.2990.1289.31102.0074.3474.5774.5774.57115.617.007.007.007.007.007.00NANANANANANA

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Long Term Debt 48.0047.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Other Liabilities Noncurrent 157.00136.00138.00140.00142.00145.00144.00145.00140.0016.1714.6813.875.2610.2010.2010.2010.258.180.690.640.811.031.281.541.792.052.312.550.56NA
Operating Lease Liability Noncurrent 99.00NANANA110.00NANANA117.00119.19121.34114.81116.8948.9449.7414.7115.24NANANANANANANANANANANANANA

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Stockholders Equity 485.00565.00635.00707.00462.00520.00566.00600.00657.00698.70747.39796.58841.45542.61604.55664.79502.30544.42428.71140.64163.84177.23196.65221.57234.94245.12254.57266.59-72.33NA
Common Stock Value 1617.001602.001582.001561.001311.001291.001267.001226.001206.000.010.010.010.010.010.010.010.010.010.010.000.000.000.000.000.00NANANANANA
Retained Earnings Accumulated Deficit -1132.00-1038.00-946.00-853.00-849.00-768.00-697.00-622.00-542.00-474.90-409.98-343.35-275.35-554.72-476.75-400.78-328.18-276.33-278.15-233.08-205.33-188.73-166.38-138.29-122.83-110.53-99.72-86.19-73.23NA
Accumulated Other Comprehensive Income Loss Net Of Tax NA1.00-1.00-1.00NA-3.00-4.00-4.00-7.00-9.80-7.24-4.66-1.26-0.09-0.05-0.000.040.080.140.290.060.050.110.03-0.11-0.11-0.08-0.10-0.04NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value NA19.0020.0020.00NA18.0018.0019.00NA16.2615.6816.54NA14.5913.3712.76NA6.004.473.46NA2.742.131.67NA1.051.120.66NANA

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Net Cash Provided By Used In Operating Activities -100.0026.00-94.00-2.00-88.00-63.00-57.00-98.00-69.74-80.96-65.30654.00-62.10-53.76-74.00-66.32-49.88216.26-23.94-31.28-9.47-27.40-19.75-16.84-7.11-11.77-10.88-13.2515.59-24.23
Net Cash Provided By Used In Investing Activities 51.00-29.0063.00-169.0028.0011.0026.00129.0046.8123.45-215.20-268.0618.91-88.613.0062.83-0.23-387.12-87.0740.06-12.1030.3626.6714.282.51-83.34-16.12-16.49-42.0712.73
Net Cash Provided By Used In Financing Activities -2.0048.002.00229.003.006.0023.001.0011.202.534.3514.9311.671.322.23222.121.68107.52328.870.610.52-0.040.65-0.010.77-0.01-1.12129.43106.600.19

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Net Cash Provided By Used In Operating Activities -100.0026.00-94.00-2.00-88.00-63.00-57.00-98.00-69.74-80.96-65.30654.00-62.10-53.76-74.00-66.32-49.88216.26-23.94-31.28-9.47-27.40-19.75-16.84-7.11-11.77-10.88-13.2515.59-24.23
Net Income Loss -94.00-92.00-93.00-4.00-81.00-71.00-75.00-80.00-67.46-64.92-66.63-67.99279.37-77.97-75.97-72.59-51.851.82-45.07-27.75-16.60-22.35-28.09-17.67-12.29-10.81-13.53-12.95-13.21-23.12
Profit Loss -94.00-92.00-93.00-4.00-81.00-71.00-75.00-80.00-67.46-64.92-66.63-67.99279.37-77.97-75.97-72.59-51.851.82-45.07-27.75-16.60-22.35-28.09-17.67-12.29-10.81-13.53-12.95-13.21NA
Increase Decrease In Accounts Payable 5.00-1.000.00-1.002.006.00-19.0010.008.05-12.163.968.140.65-1.85-11.297.726.11-3.509.01-2.341.820.47-0.05-0.520.96-2.381.65-0.312.04-0.70
Share Based Compensation 17.0019.0020.0020.0018.0018.0018.0019.0016.5216.2615.6816.5413.8114.5913.3712.767.896.004.473.462.442.742.131.671.051.051.120.660.150.14

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Net Cash Provided By Used In Investing Activities 51.00-29.0063.00-169.0028.0011.0026.00129.0046.8123.45-215.20-268.0618.91-88.613.0062.83-0.23-387.12-87.0740.06-12.1030.3626.6714.282.51-83.34-16.12-16.49-42.0712.73
Payments To Acquire Property Plant And Equipment 1.001.000.004.006.0010.005.003.000.381.321.512.798.517.866.073.641.521.070.260.210.200.550.550.630.261.131.301.050.290.84

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Net Cash Provided By Used In Financing Activities -2.0048.002.00229.003.006.0023.001.0011.202.534.3514.9311.671.322.23222.121.68107.52328.870.610.52-0.040.65-0.010.77-0.01-1.12129.43106.600.19

    2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30
Revenues 26.0048.0039.00145.0031.0032.0029.0025.0033.6633.5826.7618.00354.509.469.469.469.4964.531.751.759.751.751.751.751.564.291.251.251.250.16
Revenue From Contract With Customer Excluding Assessed Tax -181.0048.0039.00145.0031.0032.0029.0025.0033.6633.5826.7618.00354.509.469.469.469.4964.531.751.759.751.751.751.751.564.291.251.251.250.16
Gilead Sciences Inc, Etrumadenant License And Research And Development Services Agreement 11.009.003.0024.0013.0021.0010.008.0013.003.00NANANANANANANANANANANANANANANANANANANANA
Gilead Sciences Inc, Quemliclustat License And Research And Development Services Agreement 15.0013.0019.00100.006.00-4.007.008.0010.0012.002.002.00NANANANANANANANANANANANANANANANANANA
Gilead Sciences Inc, Research And Development Activities For Domvanalimab NA1.003.007.00NA1.001.001.00NANANANANANANANANANANANANANANANANANANANANANA
Gilead Sciences Inc, Research And Development Activities For Inflammation Programs 2.002.002.002.001.002.001.00NANANANANANANANANANANANANANANANANANANANANANANA
Taiho Pharmaceutical Co Ltd, Option And License Agreement -10.0018.003.004.001.004.00NANA0.002.001.002.00NANANANANANANANANANANANANANANANANANA
License And Development Services Revenue 18.0041.0028.00135.0022.0022.0019.0017.0025.6323.7416.697.941.140.000.00NANANANANANANANANANANANANANANA
Other Collaboration Revenue 8.007.0011.0010.009.0010.0010.008.008.039.8410.0710.079.539.469.469.46NANANANANANANANANANANANANANA
License And Development Services Revenue, Related Party 28.0023.0025.00131.0021.0018.0019.0017.0026.0023.00NANANANANANANANANANANANANANANANANANANANA
Other Collaboration Revenue, Related Party 8.007.0011.0010.009.0010.0010.008.008.008.00NANANANANANANANANANANANANANANANANANANANA
Access Rights, Transferred Over Time, Gilead Collaboration NA5.00NANANA8.00NANANANANANANANANANANANANANANANANANANANANANANANA
License And R D Services, Transferred Over Time, Gilead Collaboration NA25.00NANANA20.00NANANANANANANANANANANANANANANANANANANANANANANANA
License Revenue, Transferred At Point In Time, Taiho Collaboration NA15.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
R D Services, Transferred Over Time, Taiho Collaboration NA3.00NANANA4.00NANANANANANANANANANANANANANANANANANANANANANANANA
Access Rights And Option Continuation Periods 6.005.009.008.008.008.009.008.008.008.009.008.00NANANANANANANANANANANANANANANANANANA
Taiho Collaboration Agreement NA3.003.004.00NA4.00NANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Interest Expense Debt
Balance Sheet
Long Term Debt
Assets
Property Plant And Equipment Net
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Operating Lease Liability
Current Liabilities
Taxes Payable Current
Noncurrent Liabilities
Long Term Debt
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Next Twelve Months

Line plots across dimensions of each concept